Removing N-Terminal Sequences in Pre-S1 Domain Enhanced Antibody and B-Cell Responses by an HBV Large Surface Antigen DNA Vaccine

• Guohong Ge,

  Current address: The Third Hospital of Zhenjiang City, Zhenjiang, Jiangsu, China

  Affiliation Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

  ⨯
• Shixia Wang,

  Affiliations China-US Vaccine Research Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• Yaping Han,

  Affiliations Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, China-US Vaccine Research Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

  ⨯
• Chunhua Zhang,

  Affiliations Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, China-US Vaccine Research Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

  ⨯
• Shan Lu ,

  * E-mail: shan.lu@umassmed.edu

  Affiliations Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, China-US Vaccine Research Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• Zuhu Huang

  Affiliations Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, China-US Vaccine Research Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

  ⨯